A diet rich in antioxidants — such as vitamins A, C, E, and selenium and zinc — may help most…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Parkinson’s disease patients carrying the G2385R mutation in the LRRK2 gene, a known risk factor for the disease, show…
Neuron-supporting cells called astrocytes produce regular pulses of gamma-aminobutyric acid (GABA), a chemical that suppresses excessive brain activity, that appear…
A framework called the neuronal alpha-synuclein disease integrated staging system (NSD-ISS) to stage patients in the early stretch of…
A small pump that’s worn as part of a teeth retainer can continuously release high daily doses of a paste…
The first six Parkinson’s disease patients given the investigational stem cell-based therapy TED-A9 in a clinical trial showed safety…
People with Parkinson’s disease who have orthostatic hypotension — that’s where the blood pressure drops suddenly upon standing up…
While loss of dopamine is a hallmark of Parkinson’s disease, patients with tremor may actually have pools of dopamine…
Mice modeling Parkinson’s disease performed better on tests of memory and spatial recognition when given daily under-the-skin injections of…
An upcoming Phase 2 clinical trial is due to test NEU-411, a brain-penetrant oral small molecule that Neuron23…